Strota / GLAXO / Quarterly results

GlaxoSmithKline Pharmaceuticals Q1 FY27 Results: Revenue, Profit and Share Price Reaction

GlaxoSmithKline Pharmaceuticals' quarterly results from its filings with NSE, consolidated, with how the share price moved on each announcement.

Q1 FY27 (quarter to 30 Jun 2026): revenue ₹938 crore (+16.6% year on year), net profit ₹237 crore, EPS ₹14.0. Announced 3 Aug 2026, 8:36 pm IST. The shares fell 0.57% on 4 Aug 2026, 0.07 points better than the Nifty 50. Next results board meeting: 3 Nov 2026.
Revenue
₹938 cr
YoY +16.6% · QoQ -5.7%
Net profit
₹237 cr
YoY — · QoQ -14.6%
EPS (basic)
₹14.0
YoY +15.7%
Share price reaction
-0.6%
4 Aug 2026 · vs Nifty +0.1%

Revenue and net profit by quarter

RevenueNet profit
Q4 FY25 Revenue: ₹974 cr Q4 FY25 net profit: ₹0.00 cr Q4 FY25 Q1 FY26 Revenue: ₹805 cr Q1 FY26 net profit: ₹0.00 cr Q1 FY26 Q2 FY26 Revenue: ₹980 cr Q2 FY26 net profit: ₹0.00 cr Q2 FY26 Q3 FY26 Revenue: ₹1,041 cr Q3 FY26 net profit: ₹0.00 cr Q3 FY26 Q4 FY26 Revenue: ₹995 cr Q4 FY26 net profit: ₹278 cr Q4 FY26 Q1 FY27 Revenue: ₹938 cr Q1 FY27 net profit: ₹237 cr Q1 FY27

Every quarter

QuarterAnnouncedRevenueYoYNet profitYoYMarginEPSPrice reaction
Q1 FY273 Aug 2026, 8:36 pm IST 938+16.6%237— 25.3%14.0 -0.6%
Q4 FY2613 May 2026, 10:16 pm IST 995+2.1%278— 27.9%16.4 +0.2%
Q3 FY269 Feb 2026, 7:21 pm IST 1,041—0.00— 0.0%16.54 +4.2%
Q2 FY266 Nov 2025, 5:11 pm IST 980—0.00— 0.0%15.07 -0.7%
Q1 FY261 Aug 2025, 3:32 pm IST 805—0.00— 0.0%12.1 -2.3%
Q4 FY2513 May 2025, 11:17 pm IST 974—0.00— 0.0%15.52 +3.2%

₹ crore. Consolidated figures; net profit is the share attributable to the company's owners where reported. Margin = net profit ÷ revenue. Year-on-year compares with the same quarter a year earlier.

How GLAXO shares react to results

Across the last 6 results here, the shares rose on 3 and fell on 3. The average move was +0.69%, and the average size of the move either way 1.87%; the biggest was +4.24% after the Q3 FY26 results.

The reaction is the close of the first session that could trade on the news (the announcement day if it came before 3:30 pm, otherwise the next session) against the previous close. A few results don't explain a stock's move; markets also price guidance, commentary and what was expected.

Questions

What were GlaxoSmithKline Pharmaceuticals' Q1 FY27 results?

For the quarter to 30 Jun 2026, GlaxoSmithKline Pharmaceuticals reported revenue of ₹938 crore (+16.6% year on year) and net profit of ₹237 crore, with basic EPS of ₹14.0.

How did GlaxoSmithKline Pharmaceuticals shares react to the Q1 results?

They fell 0.57% on 4 Aug 2026, the first session that could trade on the results (announced after the close); that was 0.07 points better than the Nifty 50 that day.

When is GlaxoSmithKline Pharmaceuticals' next results date?

The board meets on 3 Nov 2026 to consider results, according to the company's intimation to NSE.

Do GlaxoSmithKline Pharmaceuticals shares usually rise after results?

In the last 6 results here they rose 3 times and fell 3 times, moving 1.87% on average either way.

About this data

From GlaxoSmithKline Pharmaceuticals' Integrated Filing (Financials) XBRL with NSE, which listed companies use for quarterly results since 2025; announcement times are NSE's broadcast times (IST). Share prices are NSE closing prices. See GLAXO stock page for price, open interest and deals, all results declared this week and the results calendar, and GLAXO dividend history.